Skip to main content
SpringerLink
Log in

Transurethale Resektion der Blase

  • Chapter
Endoskopische Urologie

  • 485 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Parkin MD, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25-major cancers in 1990. Int J Cancer 80: 827–841, 1999

    PubMed  CAS  Google Scholar 

  2. Miller K, Weißbach L: Leitlinien zur Diagnostik und Therapie des Harnblasenkarzinoms. Urologe A 37: 440–457, 1998

    Google Scholar 

  3. Herr HW: Natural history of superficial bladder tumors: 10-to 20-year follow up of treated patients. World J Urol 15(2): 84–88, 1997

    Article  PubMed  CAS  Google Scholar 

  4. Waters BW: Invasive bladder cancer-where do we go from here? J Urol 155: 1910–1911, 1996

    PubMed  CAS  Google Scholar 

  5. Oosterlinck W, Jakse G, Malmström P, Stöckle M, Sternberg C, Neal D, Clais da Silvam F: Guidelines on bladder carcinoma. European Assocication of Urology, 2000

    Google Scholar 

  6. Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MKB, Bijnens L: A combined analysis of European organization for research and treatment of cancer and medical research council randomized clinical trials for the prophylactic treatment of stage Ta T1-bladder cancer. J Urol 156: 1934–1941, 1996

    PubMed  CAS  Google Scholar 

  7. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani, PC, Fair WR: The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158(1): 62–67, 1997

    Article  PubMed  CAS  Google Scholar 

  8. Rübben H, Lutzeyer W, Fischer N, Deutz FJ, Lagrange W, Giani G and Members of the Registry for Urinary Tract Tumors, Rheinisch Westfälische Technische Hochschule Aachen: Natural history and treatment of low and high risk superficial bladder tumors. J Urol 139: 283, 1988

    PubMed  Google Scholar 

  9. Lamm DL: Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am 19(3): 573–580, 1992

    PubMed  CAS  Google Scholar 

  10. Schnyder von Wartensee M, Ackermann D, Studer UE, Zingg EJ: Die Behandlung des Carcinoma in situ der Harnblase mit BCG. Helv Chir Acta 56: 351, 1989

    Google Scholar 

  11. RUTT (Registry for Urinary Tract Tumors) Harnwegstumorregister. Jahresbericht. Verh Dtsch Ges Urol 37: 665, 1985

    Google Scholar 

  12. Utz DC, Farrow GM: Carcinoma in situ of the urinary tract. Urol Clin North Am 11: 735–770, 1984

    PubMed  CAS  Google Scholar 

  13. Van Gils-Gielen RJM, Debruyne FMJ, Witjes WPJ, Witjes JA, Caris CTM, Oosterhof GON: Risk factors in carcinoma in situ of the urinary bladder. Urology 45(4): 581–586, 1995

    PubMed  Google Scholar 

  14. Flocks RH: Treatment of patients with carcinoma of the bladder. JAMA 145: 295–301, 1951

    CAS  ISI  Google Scholar 

  15. Milner WA: The role of conservative surgery in the management of bladder tumours. Br J Urol 26: 375–386, 1954

    PubMed  CAS  Google Scholar 

  16. Barnes RW, Bergman RT, Hadley HL, Love D: Control of bladder tumors by endoscopic surgery. J Urol 97: 864–868, 1967

    PubMed  CAS  Google Scholar 

  17. O’Flynn JD, Smith JD, Hanson JG: Transurethral resection for the assessment and treatment of vesical neoplasm. A review of 800 consecutive cases. Eur Urol 1: 38–41, 1975

    PubMed  CAS  Google Scholar 

  18. Herr H: Conservative management of muscle-infiltrating bladder tumour. Prospective experience. J Urol 138: 1162–1163, 1987

    PubMed  CAS  Google Scholar 

  19. Henry K, Miller J, Mori M, Loening S, Fallon B: Comparison of transurethral resection to radical therapies for stage B in bladder tumors. J Urol 140: 964–967, 1988

    Google Scholar 

  20. Brausi M, Collette L, Kurth K, Van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ: Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 41: 523–531, 2002

    Article  PubMed  Google Scholar 

  21. Köhrmann KU, Woeste M, Kappes J, Rassweiler J, Alken P: Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 25: 208–213, 1994

    Google Scholar 

  22. Klän R, Loy V, Huland H: Residual tumor discovered in routine second transurethral resection in patients with stage T1-transitional cell carcinoma of the bladder. J Urol 146(2): 316–318, 1991

    PubMed  Google Scholar 

  23. Schwaibold HE, Treiber U, Kuebler H, Leyh H, Hartung R: Second transurethral resection detects histopathological changes worsening the prognosis in 25% of patients with pT1-bladder cancer. J. Urol., 163(4): 153, 2000

    Google Scholar 

  24. Wechsel HW, Rosenkranz T, Bichler KH, Petri E: Nach-und Sicherheitsresektion beim oberflächlichen, niedriggradigen Blasenkarzinom. Urologe A 35:Suppl: 118, 1996

    Google Scholar 

  25. Kurth KH, Schellhammer PF, Okajima E et al.: Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethra. Int J Urol 2[Suppl]: 8–22

    Google Scholar 

  26. Köhrmann KU, Woeste M, Kappes J, Rassweiler J, Alken P: Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 25: 208–213, 1994

    Google Scholar 

  27. Klän R, Loy V, Huland H: Residual tumor discovered in routine second transurethral resection in patients with stage T1-transitional cell carcinoma of the bladder. J Urol 146(2): 316–318, 1991

    PubMed  Google Scholar 

  28. Schwaibold HE, Treiber U, Kuebler H, Leyh H, Hartung R: Second transurethral resection detects histopathological changes worsening the prognosis in 25% of patients with pT1-bladder cancer. J. Urol., 163(4): 153, 2000

    Google Scholar 

  29. Wechsel HW, Rosenkranz T, Bichler KH, Petri E: Nach-und Sicherheitsresektion beim oberflächlichen, niedriggradigen Blasenkarzinom. Urologe A 35:Suppl: 118, 1996

    Google Scholar 

  30. Halachami S, Linn JF, Amiel GE, Moskovitz B, Nativ O: Urine cytology, tumour markers and bladder cancer. Br J Urol 82(5): 647–654, 1998

    Google Scholar 

  31. Denis L, Nowé P, Declercq G: Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers. Eur Urol 6: 137–138, 1980

    PubMed  CAS  Google Scholar 

  32. Zein TA, Wajsman Z, Englander LS, Gamarra M, Lopez C, Huben RP, Pontes JE: Evaluation of bladder washings and urin cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder Mucosa. J Urol, 132: 670–671, 1984

    PubMed  CAS  Google Scholar 

  33. Zein TA, Milad MF: Urine cytology in bladder tumors. Int Surg 76(1): 52–54, 1991

    PubMed  CAS  Google Scholar 

  34. Gregoire M, Fradet Y, Meyer F, Tetu B, Bois R, Bedard G, Charrois R, Naud A: Diagnostic accuracy of urinary cytology, and deoxyriboncleolic acid flow cytometry and cytology on bladder washings during followup for bladder tumors. J Urol 157: 1660–1664, 1997

    PubMed  CAS  Google Scholar 

  35. Kiemeney LA, Witjes JA, Hejbroek RP, Koper NP, Verbeek AL, Debruyne FM: Should random biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group. Br J Urol 73: 1764–1771, 1994

    Article  Google Scholar 

  36. Harving N, Wolf H, Melsen F: Positive urinary cytology after tumor resection: An indicator for concomitant carcinoa in situ. J Urol 140: 495–497, 1988

    PubMed  CAS  Google Scholar 

  37. Jocham D, Baumgartner R, Fuchs N, Lenz H, Stepp H, Unsöld E: Die Fluoreszenzdiagnose Porphyrin-markierter urothelialer Tumoren. Urologe A 28: 59–64, 1989

    PubMed  CAS  ISI  Google Scholar 

  38. Kriegmair M, Stepp H, Steinbach P, Lumper W, Ehsan A, Stepp HG, Rick K, Knüchel R, Baumgartner R, Hofstetter A: Fluorescence Cystoscopy following intravesical instillation of 5-aminolevulinic acid: A new procedure with high sensitivity for detection of hardly visible urothelial neoplasias. Urol Int 55: 190–196, 1995

    Article  PubMed  CAS  Google Scholar 

  39. Steinbach P, Kriegmair M, Baumgartner R, Hofstädter F, Knüchel R: Intravesical instillation of 5-aminolevulinic acid: The fluorescent metabolite is limited to urothelial cells. Urology 44(5): 676–681, 1994

    PubMed  CAS  ISI  Google Scholar 

  40. Steinbach P, Weingandt H, Baumgartner R, Kriegmair M, Hofstädter F, Knüchel R: Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolaevulinic acid. Photochem Photobiol 62: 887–895, 1995

    PubMed  CAS  Google Scholar 

  41. Kriegmair M, Baumgartner R, Knuechel R, Stepp H, Hofstädter F, Hofstetter A: Detection of early bladder cancer by 5-aminolev ulinic acid induced porphyrin fluorescence. J Urol 155: 105–109, 1996

    PubMed  CAS  Google Scholar 

  42. Zaak D, Kriegmair M, Stepp H, Baumgartner R, Oberneder R, Schneede P, Corvin S, Frimberger D, Knuechel R, Hofstetter A: Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: Results of 1012-fluorescence endoscopies. Urology 57: 690–694, 2001

    Article  PubMed  CAS  ISI  Google Scholar 

  43. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagniers G, Zimmer G, Guillou L, Schmidlin F, Graber P, van den Bergh H, Leisinger HJ: Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 20(4): 402–408, 1997

    Article  PubMed  CAS  Google Scholar 

  44. Filbeck T, Roessler W, Knuechel R, Straub M, Kiel HJ, Wieland WF: Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of FD after intravesical instillation of 5-aminolevulinic acid. J Endourol 13(2): 117–121, 1999

    PubMed  CAS  Google Scholar 

  45. De Dominicis C, Liberti M, Perugia G, De Nunzio C, Sciobica F, Zuccala A, Sarkozy A, Iori F: Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: Improvement in diagnostic sensitivity. Urology 57: 1059–1062, 2001

    PubMed  Google Scholar 

  46. Kriegmair M, Waidlich R, Lumper W, Ehsan A, Baumgartner R, Hofstetter A: Integral photodynamic treatment of refractory superficial bladder cancer. J Urol 154: 1339–1341, 1995

    PubMed  CAS  Google Scholar 

  47. Kennedy JC, Pottier RH.: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol 14(4): 275–292, 1992

    CAS  Google Scholar 

  48. Kriegmair M, Baumgartner R, Knuechel R, Steinbach P, Ehsan A, Lumper W, Hofstädter F, Hofstetter A: Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44(6): 836–841, 1994

    Article  PubMed  CAS  ISI  Google Scholar 

  49. Krieg R, Fickweiler S, Wolfbeis OS, Knuechel R: Cell-type specific protoporphyrin IX metabolism in Human bladder cancer in vitro. Photochem Photobiol 72(2): 226–228, 2000

    Article  PubMed  CAS  Google Scholar 

  50. Kriegmair M, Baumgartner R, Knuechel R, Stepp H, Hofstädter F, Hofstetter A: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155: 105–109, 1996

    PubMed  CAS  Google Scholar 

  51. Zaak D, Kriegmair M, Stepp H, Baumgartner R, Oberneder R, Schneede P, Corvin S, Frimberger D, Knuechel R, Hofstetter A: Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: Results of 1012-fluorescence endoscopies. Urology 57: 690–694, 2001

    Article  PubMed  CAS  ISI  Google Scholar 

  52. Jichlinski P, Forrer M, Mizeret J, Glanzmann T, Braichotte D, Wagniers G, Zimmer G, Guillou L, Schmidlin F, Graber P, van den Bergh H, Leisinger HJ: Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med 20(4): 402–408, 1997

    Article  PubMed  CAS  Google Scholar 

  53. Filbeck T, Roessler W, Knuechel R, Straub M, Kiel HJ, Wieland WF: Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of FD after intravesical instillation of 5-aminolevulinic acid. J Endourol 13(2): 117–121, 1999

    PubMed  CAS  Google Scholar 

  54. De Dominicis C, Liberti M, Perugia G, De Nunzio C, Sciobica F, Zuccala A, Sarkozy A, Iori F: Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: Improvement in diagnostic sensitivity. Urology 57: 1059–1062, 2001

    PubMed  Google Scholar 

  55. Filbeck T, Pichlmeier U, Knuechel R, Roessler W, Wieland WF: Do patients profit from 5-aminolevulinic acid-induced fluorescence diagnosis in transurethral resection of bladder carcinoma? Urology 60: 1025–1028, 2003

    ISI  Google Scholar 

  56. Jeon SS, Kang I, Hong JH, Choi HY, Chai SE: Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms. J Endourol 15(7): 753–759 2001

    Article  PubMed  CAS  Google Scholar 

  57. Riedl CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H: Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer. J Urol 165: 1121–1123, 2001

    PubMed  CAS  Google Scholar 

  58. Zaak D, Frimberger D, Muller-Lisse U, Hofstetter A, Pichlmeier U, Kriegmair M: Decrease of early recurrence by means of 5-aminolevulinic induced fluorescence endoscopy in patients with bladder cancer follow up of a randomized phase III trial. J Urol 165(5): 165, 2001

    Google Scholar 

  59. Filbeck T, Pichlmeier U, Knuechel R, Wieland WF, Roessler W: Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid-induced fluorescence diagnosis in patients with superficial bladder tumours. J Urol 168: 67–71, 2002

    PubMed  Google Scholar 

  60. Piechota H, Waldner M, Roth S: Tipps & Tricks für den Urologen. Problemlösungen von A-Z. Springer, Berlin Heidelberg New York, S 228, 1998

    Google Scholar 

  61. Filbeck T, Rössler W, Straub M: Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolaevulinic acid. J Endourol 13(2): 117–121, 1999

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik, Urologie der Universität Regensburg am Caritas Krankenhaus, St. Josef Landshuter Straße 65, 93053, Regensburg

    Prof. Dr. med. Wolf Wieland (Direktor)

  2. Westenstraße 2, 85072, Eichstätt

    Priv.-Doz. Dr. med. Thomas Filbeck

  3. Klinik und Poliklinik, Urologie der Universität Regensburg am Caritas Krankenhaus, St. Josef Landshuter Straße 65, 93953, Regensburg

    Priv.-Doz. Dr. med. Thomas Filbeck

Authors
  1. Prof. Dr. med. Wolf Wieland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priv.-Doz. Dr. med. Thomas Filbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Urologie und Kinderurologie, Philipps-Universität Marburg, Baldingerstraße, 35033, Marburg

    Rainer Hofmann (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Wieland, W., Filbeck, T. (2005). Transurethale Resektion der Blase. In: Hofmann, R. (eds) Endoskopische Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28923-2_11

Download citation

  • DOI: https://doi.org/10.1007/3-540-28923-2_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20679-8

  • Online ISBN: 978-3-540-28923-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation